Anthony Zezzo

Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ.

The American Association of Blood Banks is a professional organization dedicated to advancing the field of transfusion medicine and cellular therapies. The non-profit company is based in Bethesda, MD and has subsidiaries in Puerto Rico. The association provides accreditation and certification programs for blood banks and transfusion services, as well as educational resources and advocacy efforts.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Paradigm Diagnostics, Inc. develops, manufactures and distributes high throughput microbiological screening tests. It has developed and is currently selling diagnostic tests to the food processing industry that allow them to screen environmental samples for pathogens in- house. The company was founded by Alan D. Olstein in 2001 and is headquartered in St. Paul, MN.

Blue Cross & Blue Shield of Massachusetts, Inc. provides indemnity insurance and medicare extension programs. The firm offers medical and dental plans, pharmacy coverage, vision coverage and health savings accounts. The company was founded in 1937 and is located in Boston, MA.

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

Blue Cross & Blue Shield of Arizona, Inc. engages in the provision of health insurance products and services. It offers various health plans for individuals, families, and small and large businesses. The company was founded in 1939 and is headquartered in Phoenix, AZ.

Rain Bird Corp., Inc. manufactures and distributes residential and light commercial irrigation products. Its products include plumbing fixtures, fittings, trim, lawn hose nozzles and sprinklers. The company was founded by Mary E. LaFetra in 1933 and is headquartered in Azusa, CA.

Johnson & Johnson Health Care Systems, Inc. provides account management and customer support services. The firm services include contract management, e-business and supply chain. It provides services to health care organizations, hospitals, physician networks and government customers. The company is headquartered in Piscataway, NJ

University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA.

Greater Boston Chamber of Commerce is a non profit organization. It offers business community services and programs such as government affairs forums, executive forums, women’s network, city awake, chamber networking group, city to city, and webinars. The company was founded in 1909 and is headquartered in Boston, MA.

Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009.

Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022.

The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry.

Allscripts Healthcare LLC provides computer related services. The company was founded on May 25, 2000 and is headquartered in Raleigh, NC.

GenePeeks, Inc. develops software that provides genetic information to reduce the risk of heritable diseases. It simulates the genetic reduction and recombination by digitally weaving together the DNA of prospective parents. The company was founded by Anne Morriss and Lee Silver in 2009 and is headquartered in Albany, NY.

IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California.

Trinnovate Ventures, Inc. (Trinnovate Ventures) is a venture capital firm, a subsidiary of Blue Cross & Blue Shield of Arizona, Inc. founded in 2015. The firm is headquartered in Phoenix, Arizona.

BlueStone Venture Partners LLC (BlueStone Venture Partners) is a venture capital firm founded in 2017 by Mara G. Aspinall and Tom Nickoloff. The firm is headquartered in Tucson, Arizona.

ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL.

Strateos engages in the automation of chemistry, biology, and tissue analysis into closed loop robotic laboratories that support drug discovery programs. The company is headquartered in the Menlo Park, CA.

Pyx Health, Inc. engages in the provision of healthcare services. The company was founded by Cynthia Jordan in 2017 and is headquartered in Tucson, AZ.

Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020.